There are no FDA fully approved agents for the treatment of relapsed PTCL and the FDA has granted soquelitinib Orphan Drug Designation for the treatment of T cell lymphoma and Fast Track designation .
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback